Inicio › Linfoma › Carolina del Norte › Durham
Ensayos clínicos de Linfoma en Durham, NC
17 estudios para Linfoma buscan participantes en centros de Durham y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
ReclutandoFase 3
- Duke Cancer Institute, Durham
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
ReclutandoFase 2
- Duke University, Durham
A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
ReclutandoFase 2
- Durham VA Medical Center, Durham, NC, Durham
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
ReclutandoEstudio observacional
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · A 10 mi de distancia
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
ReclutandoFase 1/2
- University of North Carolina at Chapel Hill/ University of North Carolina Medical Center, Chapel Hill · A 10 mi de distancia
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
ReclutandoFase 1/2
- Duke University Medical Center, Duke Cancer Center, Durham
CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma
ReclutandoFase 2
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill · A 10 mi de distancia
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
ReclutandoFase 1/2
- Duke University Medical Center, Durham
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
ReclutandoFase 1/2
- UNC School of Medicine, Division of Hematology, Chapel Hill · A 10 mi de distancia
DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics
Reclutando
- Lineberger Comphrehensive Cancer Center at University of North Carolina, Chapel Hill · A 10 mi de distancia
DALY II USA/ MB-CART2019.1 for DLBCL
ReclutandoFase 2
- Duke University Medical Center - Division of Hematologic Malignancies, Durham
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
ReclutandoFase 1
- Duke University Medical Center, Durham
Combating Cancer-Related Fatigue: A Personalized Supportive Care Program
Reclutando
- North Carolina Basnight Cancer Hospital, Chapel Hill · A 10 mi de distancia
Registry of Older Patients With Cancer
ReclutandoEstudio observacional
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · A 10 mi de distancia
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
ReclutandoFase 2
- University of North Carolina, Chapel Hill · A 10 mi de distancia
Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors
Reclutando
- Duke Cancer Institute, Durham
Study of Kappa Chimeric Antigen Receptor (CAR) T Lymphocytes Co-Expressing the Kappa and CD28 CARs for Relapsed/Refractory Kappa+ Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
ReclutandoFase 1
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill · A 10 mi de distancia
Más información sobre Linfoma en MedlinePlus
Ensayos de Linfoma en otras ciudades
- Houston, TX34 estudios
- Boston, MA34 estudios
- New York City, NY33 estudios
- Washington, DC23 estudios
- Baldwin Park, CA22 estudios
- Chicago, IL19 estudios
- St. Louis, MO15 estudios
- Cleveland, OH13 estudios
- Seattle, WA13 estudios
- Atlanta, GA13 estudios
- Philadelphia, PA13 estudios
- Edison, NJ12 estudios
Otros estudios en Durham
- Cáncer de seno63 estudios
- Cáncer (todos los tipos)61 estudios
- Cáncer de pulmón de células no pequeñas42 estudios
- Mieloma múltiple36 estudios
- Leucemia mielógena aguda34 estudios
- Cáncer de pulmón33 estudios
- Cáncer metastásico33 estudios
- Cáncer de próstata32 estudios
- Cáncer del colon y del recto30 estudios
- Cáncer de ovario28 estudios
- Leucemia linfocítica crónica28 estudios
- Fallo cardíaco25 estudios
De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.